73 related articles for article (PubMed ID: 3159614)
1. Augmentation of the cell-mediated cytotoxic response induced in mixed cell culture by adriamycin.
Arinaga S; Akiyoshi T; Tsuji H
Jpn J Cancer Res; 1985 May; 76(5):414-9. PubMed ID: 3159614
[TBL] [Abstract][Full Text] [Related]
2. Augmentation of the generation of cell-mediated cytotoxicity after a single dose of adriamycin in cancer patients.
Arinaga S; Akiyoshi T; Tsuji H
Cancer Res; 1986 Aug; 46(8):4213-6. PubMed ID: 3488123
[TBL] [Abstract][Full Text] [Related]
3. Augmentation of the development of immune responses of mice against allogeneic tumor cells after adriamycin treatment.
Tomazic V; Ehrke MJ; Mihich E
Cancer Res; 1981 Sep; 41(9 Pt 1):3370-6. PubMed ID: 7260903
[TBL] [Abstract][Full Text] [Related]
4. Depression of the generation of cell-mediated cytotoxicity by suppressor cells after surgery.
Miyazaki S; Akiyoshi T; Arinaga S; Koba F; Wada T; Tsuji H
Clin Exp Immunol; 1983 Nov; 54(2):573-9. PubMed ID: 6228356
[TBL] [Abstract][Full Text] [Related]
5. Cellular basis for adriamycin-induced augmentation of cell-mediated cytotoxicity in culture.
Ehrke MJ; Ryoyama K; Cohen SA
Cancer Res; 1984 Jun; 44(6):2497-504. PubMed ID: 6426781
[TBL] [Abstract][Full Text] [Related]
6. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
Colotta F; Peri G; Villa A; Mantovani A
J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
[TBL] [Abstract][Full Text] [Related]
7. Monocyte-mediated augmentation of human natural killer cell activity: conditions, monocyte and effector cell characteristics.
Bloom ET; Babbitt JT; Kawakami K
J Immunol; 1986 Jul; 137(1):172-8. PubMed ID: 3711665
[TBL] [Abstract][Full Text] [Related]
8. Induction of cytolytic activity by anti-T3 monoclonal antibody. Activation of alloimmune memory cells and natural killer cells from normal and immunodeficient individuals.
Suthanthiran M; Williams PS; Solomon SD; Rubin AL; Stenzel KH
J Clin Invest; 1984 Dec; 74(6):2263-71. PubMed ID: 6392343
[TBL] [Abstract][Full Text] [Related]
9. Correlation between adriamycin-induced augmentation of interleukin 2 production and of cell-mediated cytotoxicity in mice.
Ehrke MJ; Maccubbin D; Ryoyama K; Cohen SA; Mihich E
Cancer Res; 1986 Jan; 46(1):54-60. PubMed ID: 3484381
[TBL] [Abstract][Full Text] [Related]
10. Augmentation by anti-T3 antibody of the lymphokine-activated killer cell-mediated cytotoxicity.
Ting CC; Hargrove ME; Yun YS
J Immunol; 1988 Aug; 141(3):741-8. PubMed ID: 3260909
[TBL] [Abstract][Full Text] [Related]
11. Depression of the generation of cell-mediated cytotoxicity by macrophage-like suppressor cells in bladder carcinoma patients.
Spina CA; Dorey F; Vescera C; Brosman S; Fahey JL
Cancer Res; 1981 Nov; 41(11 Pt 1):4324-30. PubMed ID: 6458353
[TBL] [Abstract][Full Text] [Related]
12. LY-2+ effectors cytotoxic for syngeneic tumor cells: generation by allogeneic stimulation and by supernatants from mixed leukocyte cultures.
Hurrell SM; Zarling JM
J Immunol; 1983 Aug; 131(2):1017-23. PubMed ID: 6223084
[TBL] [Abstract][Full Text] [Related]
13. Sensitization of lymphocytes against pooled allogeneic cells. II. Characterization of effector cells cytotoxic for autologous lymphoblastoid cell lines.
Zarling JM; Bach FH; Kung PC
J Immunol; 1981 Jan; 126(1):375-8. PubMed ID: 6450239
[TBL] [Abstract][Full Text] [Related]
14. Lectin-dependent cell-mediated cytotoxicity and blastogenesis by large granular-enriched and depleted lymphocytes.
Perl A; Gonzalez-Cabello R; Laskay T; Benczur M; Láng I; Onódy K; Nékám K; Gergely P; Fehér J
Clin Exp Immunol; 1986 Jan; 63(1):171-8. PubMed ID: 3955881
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of lymphokine-activated killer cells generation in vitro by soluble factors released from mixed human tumor and peripheral blood mononuclear adherent cells culture.
Eisenthal A; Barbarsteyn E; Gitstein G; Lifschitz-Mercer B
Cancer Invest; 2006 Feb; 24(1):28-34. PubMed ID: 16466989
[TBL] [Abstract][Full Text] [Related]
16. Leu-Leu-OMe sensitivity of human activated killer cells: delineation of a distinct class of cytotoxic T lymphocytes capable of lysing tumor targets.
Thiele DL; Lipsky PE
J Immunol; 1986 Aug; 137(4):1399-406. PubMed ID: 3488348
[TBL] [Abstract][Full Text] [Related]
17. Studies on the mechanism of suppression of primary cytotoxic responses by cloned cytotoxic T lymphocytes.
Fink PJ; Rammensee HG; Benedetto JD; Staerz UD; Lefrancois L; Bevan MJ
J Immunol; 1984 Oct; 133(4):1769-74. PubMed ID: 6236258
[TBL] [Abstract][Full Text] [Related]
18. Depression of the generation of cell-mediated cytotoxicity in regional lymph nodes of patients with gastric carcinoma.
Koba F; Akiyoshi T; Tsuji H
J Clin Lab Immunol; 1987 Apr; 22(4):181-4. PubMed ID: 3497276
[TBL] [Abstract][Full Text] [Related]
19. Limiting dilution analysis of the frequency of human T cells and large granular lymphocytes proliferating in response to interleukin 2. I. The effect of lectin on the proliferative frequency and cytotoxic activity of cultured lymphoid cells.
Vose BM; Bonnard GD
J Immunol; 1983 Feb; 130(2):687-93. PubMed ID: 6600251
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates.
Bonavida B; Lebow LT; Bradley TP
J Immunol; 1984 Feb; 132(2):594-8. PubMed ID: 6606675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
